Nektar Therapeutics | NKTR - 負債





負債 変化する 日付
Agios Pharmaceuticals USD 40.21M 4.31M 2025-12
ALKERMES USD 70M 1.6M 2025-12
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amgen USD 54.6B 17M 2025-12
Baxter International USD 9.78B 68M 2025-12
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 6.56B 275.1M 2026-03
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Cara Therapeutics USD 0 0 2025-03
Cipla INR 4.38B 231.9M 2025-03
Dr.Reddys Laboratories INR 67.73B 9.19B 2025-12
Eisai JPY 236.67B 49.14B 2025-09
Eli Lilly USD 42.5B 3.6M 2025-12
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Exelixis USD 173.04M 3.42M 2025-12
Gilead Sciences USD 24.94B 5M 2025-12
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Grifols EUR 9.23B 626.05M 2024-12
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
Incyte USD 39.43M 982K 2026-03
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
MacroGenics USD 37.01M 238K 2025-09
Merck USD 49.34B 7.97B 2025-12
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 415.3M 13.1M 2025-12
Novartis USD 47B 11.62B 2026-03
Pfizer USD 63.96B 3.11B 2025-12
Roche Holding CHF 33.03B 1.41B 2025-06
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Takeda JPY 4.85T 208B 2025-12
Teva Pharmaceutical Industries USD 17.09B 21M 2025-12
Xencor USD 69.27M 1.34M 2025-09